Detection rates of congenital heart disease in Guatemala

Sara M Trucco1, Joaquin Barnoya, Luis Alesandro Larrazabal

  • 1Pediatric Cardiology, University of California San Francisco, 94143, United States of America. smtrucco@gmail.com

Cardiology in the Young
|December 9, 2010
PubMed

Insights

Congenital heart disease (CHD) detection in Guatemala is low, with rates varying by region. Early detection of CHD in infants is crucial for improving outcomes in developing countries.

Area of Science:

  • Pediatric Cardiology
  • Global Health
  • Public Health

Background:

  • Congenital heart disease (CHD) is a significant cause of morbidity and mortality in developing nations.
  • Guatemala offers accessible pediatric cardiac care, highlighting the need for early CHD detection.

Purpose of the Study:

  • To assess regional congenital heart disease (CHD) detection rates in Guatemala.
  • To determine the correlation between regional CHD detection rates and the human development index (HDI).

Main Methods:

  • Retrospective review of new cardiac referrals in 2006 to Guatemala's sole pediatric cardiac center.
  • Calculation of regional CHD detection rates using referral data and national birth statistics.
  • Spearman's rank correlation analysis comparing regional detection rates with the 2006 Human Development Program Report data.

Main Results:

  • An estimated 3935 infants had CHD in 2006, with only 14% (533) referred for care.
  • Regional detection rates varied from 3.2% to 34%, showing a significant positive correlation with the regional human development index (r = 0.75, p < 0.0001).
  • Referred patients were predominantly older children with less severe conditions, and only 11.5% were neonates.

Conclusions:

  • Congenital heart disease (CHD) detection in Guatemala is alarmingly low and socioeconomically stratified.
  • The findings suggest a high mortality rate for Guatemalan neonates with complex cardiac defects due to delayed diagnosis.
  • Improving early CHD detection, particularly in less developed regions, is critical to reduce mortality and improve outcomes.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...